↓ Skip to main content

Dove Medical Press

Clinical use of the Oncotype DX genomic test to guide treatment decisions for patients with invasive breast cancer

Overview of attention for article published in Breast cancer targets and therapy, May 2017
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#42 of 324)
  • High Attention Score compared to outputs of the same age (81st percentile)
  • Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

news
1 news outlet
patent
1 patent

Citations

dimensions_citation
96 Dimensions

Readers on

mendeley
148 Mendeley
Title
Clinical use of the Oncotype DX genomic test to guide treatment decisions for patients with invasive breast cancer
Published in
Breast cancer targets and therapy, May 2017
DOI 10.2147/bctt.s109847
Pubmed ID
Authors

Terri P McVeigh, Michael J Kerin

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 148 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 148 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 26 18%
Student > Ph. D. Student 19 13%
Student > Master 15 10%
Researcher 13 9%
Other 11 7%
Other 24 16%
Unknown 40 27%
Readers by discipline Count As %
Medicine and Dentistry 38 26%
Biochemistry, Genetics and Molecular Biology 30 20%
Agricultural and Biological Sciences 11 7%
Pharmacology, Toxicology and Pharmaceutical Science 5 3%
Economics, Econometrics and Finance 3 2%
Other 16 11%
Unknown 45 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 September 2023.
All research outputs
#3,416,577
of 25,382,440 outputs
Outputs from Breast cancer targets and therapy
#42
of 324 outputs
Outputs of similar age
#59,210
of 324,557 outputs
Outputs of similar age from Breast cancer targets and therapy
#6
of 20 outputs
Altmetric has tracked 25,382,440 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 324 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.0. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 324,557 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.